Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data

ConclusionME/CFS patients with joint hypermobility, particularly those with EDS, demonstrate distinct clinical characteristics, including more severe symptomatology and reduced HRQOL. These findings highlight the need for comprehensive clinical assessments of ME/CFS patients with joint hypermobility. Understanding these relationships could aid in subgroup identification, improving diagnosis, and informing targeted therapeutic approaches. Further research is warranted to explore these associations and their implications for clinical practice.
Source: Frontiers in Neurology - Category: Neurology Source Type: research